BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24433561)

  • 1. Prevention of recurrent ischemic priapism with ketoconazole: evolution of a treatment protocol and patient outcomes.
    Hoeh MP; Levine LA
    J Sex Med; 2014 Jan; 11(1):197-204. PubMed ID: 24433561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Prevention of recurrent ischemic priapism with ketoconazole: evolution of a treatment protocol and patient outcomes.
    Morey AF
    J Urol; 2015 Jan; 193(1):251. PubMed ID: 25523688
    [No Abstract]   [Full Text] [Related]  

  • 3. Ketoconazole and prednisone to prevent recurrent ischemic priapism.
    Abern MR; Levine LA
    J Urol; 2009 Oct; 182(4):1401-6. PubMed ID: 19683289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Recurrent Ischemic Priapism 2014: A Complex Condition with Devastating Consequences.
    Hoeh MP; Levine LA
    Sex Med Rev; 2015 Mar; 3(1):24-35. PubMed ID: 27784569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malleable penile prosthesis is a cost-effective treatment for refractory ischemic priapism.
    Tausch TJ; Zhao LC; Morey AF; Siegel JA; Belsante MJ; Seideman CA; Flemons JR
    J Sex Med; 2015 Mar; 12(3):824-6. PubMed ID: 25536880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors.
    Anele UA; Burnett AL
    J Sex Med; 2015 Mar; 12(3):713-9. PubMed ID: 25572153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical treatment of recurrent ischaemic priapism: a review of current molecular therapeutics and a new clinical management paradigm.
    Joice GA; Liu JL; Burnett AL
    BJU Int; 2021 May; 127(5):498-506. PubMed ID: 33606327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priapism and sickle-cell anemia: diagnosis and nonsurgical therapy.
    Broderick GA
    J Sex Med; 2012 Jan; 9(1):88-103. PubMed ID: 21699659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen blockade for the treatment of high-flow priapism.
    Mwamukonda KB; Chi T; Shindel AW; Lue TF
    J Sex Med; 2010 Jul; 7(7):2532-7. PubMed ID: 20456623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease.
    Burnett AL; Anele UA; Trueheart IN; Strouse JJ; Casella JF
    Am J Med; 2014 Jul; 127(7):664-8. PubMed ID: 24680796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regimented Phosphodiesterase Type 5 Inhibitor Use Reduces Emergency Department Visits for Recurrent Ischemic Priapism.
    Hou LT; Burnett AL
    J Urol; 2021 Feb; 205(2):545-553. PubMed ID: 32915079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare Disorders of Painful Erection: A Cohort Study of the Investigation and Management of Stuttering Priapism and Sleep-Related Painful Erection.
    Johnson MJ; McNeillis V; Chiriaco G; Ralph DJ
    J Sex Med; 2021 Feb; 18(2):376-384. PubMed ID: 33390335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
    Morrison BF; Reid M; Madden W; Burnett AL
    Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of oral ketoconazole to prevent postoperative erections following penile surgery.
    Evans KC; Peterson AC; Ruiz HE; Costabile RA
    Int J Impot Res; 2004 Aug; 16(4):346-9. PubMed ID: 14973533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Diagnosis and Management of Recurrent Ischemic Priapism, Priapism in Sickle Cell Patients, and Non-Ischemic Priapism: An AUA/SMSNA Guideline.
    Bivalacqua TJ; Allen BK; Brock GB; Broderick GA; Chou R; Kohler TS; Mulhall JP; Oristaglio J; Rahimi LL; Rogers ZR; Terlecki RP; Trost L; Yafi FA; Bennett NE
    J Urol; 2022 Jul; 208(1):43-52. PubMed ID: 35536142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penoscrotal Decompression-Promising New Treatment Paradigm for Refractory Ischemic Priapism.
    Fuchs JS; Shakir N; McKibben MJ; Mathur S; Teeple S; Scott JM; Morey AF
    J Sex Med; 2018 May; 15(5):797-802. PubMed ID: 29550463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism.
    Burnett AL; Bivalacqua TJ; Champion HC; Musicki B
    J Sex Med; 2006 Nov; 3(6):1077-1084. PubMed ID: 17100941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemic priapism in South-East Nigeria: Presentation, management challenges, and aftermath issues.
    Ugwumba FO; Ekwedigwe HC; Echetabu KN; Okoh AD; Nnabugwu I; Ugwuidu ES
    Niger J Clin Pract; 2016; 19(2):207-11. PubMed ID: 26856282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketoconazole for prevention of postoperative penile erection.
    Stock JA; Kaplan GW
    Urology; 1995 Feb; 45(2):308-9. PubMed ID: 7855979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism.
    Burnett AL; Bivalacqua TJ; Champion HC; Musicki B
    Urology; 2006 May; 67(5):1043-8. PubMed ID: 16698365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.